Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04768543 · ClinicalTrials.gov registry record
Stimulation Therapy for Apnea: Reporting Thoughts
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 26
- Enrollment target
NCT04768543 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 26 participants.
The verdict
NCT04768543 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
Upper airway stimulation (UAS) via unilateral implantation of a phasic hypoglossal nerve stimulation device is a safe and effective alternative treatment for patients with moderate to severe obstructive sleep apnea (OSA) who are unwilling or unable to adhere to positive airway pressure (PAP) therapy. Although adherence to UAS is higher than to PAP, there remain patients who are not using UAS consistently. The aim of this project is to explore critical factors in the use of UAS by OSA patients using qualitative research methods (personal interviews). The proposed study will provide crucial information about patients' concerns regarding UAS use and suggestions for how to support new UAS recipients.
Interventions
- DEVICE Upper airway stimulation (Inspire Medical Systems, Inc.)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-03-02 |
| Est. Completion | 2021-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04768543
The ClinicalTrials.gov registry entry for NCT04768543 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Upper airway stimulation (Inspire Medical Systems, Inc.) is the first listed.
NCT04768543 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04768543 about?
NCT04768543 is a clinical study titled "Stimulation Therapy for Apnea: Reporting Thoughts". Upper airway stimulation (UAS) via unilateral implantation of a phasic hypoglossal nerve stimulation device is a safe and effective alternative treatment for patients with moderate to severe obstructive sleep apnea (OSA) who are unwilling or unable to adhere to positive airway pressure (PAP) therapy...
What is the current status of trial NCT04768543?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2020-03-02. Estimated completion is 2021-05-01.
What interventions are being tested in trial NCT04768543?
The interventions under investigation include: Upper airway stimulation (Inspire Medical Systems, Inc.) (DEVICE).
Who is sponsoring clinical trial NCT04768543?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.